Neuroscience at NUI Galway Gains International Excellence Status
Tuesday, 18 December 2012
The Galway Neuroscience Cluster, based within the National Centre for Biomedical Engineering Science (NCBES) at NUI Galway, last week gained the status of Centre of Excellence in Neurodegeneration (COEN) after a national and international review process. By gaining COEN status, the Galway Neuroscience Cluster joins a select group of international centres that are entitled to apply for research funding that is awarded through this international initiative.
Leader of the Neuroscience Cluster, NUI Galway’s Dr David Finn, said: “This is a very significant achievement by the Neuroscience Cluster and it represents international recognition and approval of the quantity and quality of our research over the past 5-10 years. I would like to acknowledge the efforts and support of all members of the Neuroscience Cluster and University which have contributed significantly to this exciting development.”
The overall aim of the COEN initiative is to build collaborative research activity in neurodegeneration research across borders, focusing on critical mass and excellence.
Congratulating those involved NUI Galway President, Dr Jim Browne said: "NUI Galway’s designation as a Centre of Excellence in Neurodegeneration is a wonderful endorsement of the calibre of research underway at this University. It underscores the growing international reputation of our University and its researchers. This designation will enable the Galway Neuroscience Cluster to further develop and to join an elite group of international centres working on advancing new therapies for a range of medical conditions."
The news came on the eve of the annual research meeting of the Galway Neuroscience Cluster last Thursday at NUI Galway. This meeting showcased the best of neuroscience research in the University. Attendees included undergraduate and postgraduate students as well as post-doctoral research scientists and academic members of staff from a number of different disciplines and research centers within university. The research presented encompassed a number of different areas within neuroscience. The presentations included the genetic approaches taken to improve the symptoms of Huntington’s disease, the potential use of marine products in neuroscience, the use of new delivery methods for therapies in Parkinson’s disease, the development of relevant models to study chronic pain as well as a keynote lecture given by Professor Ciaran Regan of UCD on the development of potential therapies for autism spectrum disorders.
Awards for the best postgraduate oral and poster presentations at the meeting were also presented by Dr John Newell of the Clinical Research Facility in Galway who sponsored the meeting. The poster prize was won by Jason Ridge (Anatomy and Psychiatry, NUI Galway) whose work detailed the changes in size of certain brain regions in patients with schizophrenia. Ben Newland (Network of Excellence for Functional Biomaterials, NUI Galway) won the oral presentation prize for presenting his work on the development of a new strategy to delivery genes for the treatment of Parkinson’s disease. Nikita Burke (Physiology and Centre for Pain Research) won the runner-up prize for her work on the effects of early life stress on the perception of pain.
The mission of the Neuroscience Cluster is to develop Neuroscience in Galway through research, education and community initiatives. The Cluster is truly multidisciplinary in membership, bringing together researchers from a range of clinical and preclinical disciplines, which enable the investigation of nervous system disease at a number of levels. Cluster Leader Dr David Finn added: “I would like to congratulate the prizewinners and all those who presented and contributed to a fascinating meeting and I look forward to the continued growth and success of neuroscience at NUI Galway in 2013 and beyond.”
Author: Marketing and Communications Office, NUI Galway
Visit our press centre
31 August 2015
New Programme to Get People Moving for Health
25 August 2015
CÚRAM Leads Novel Treatment for Parkinson’s Disease